131 related articles for article (PubMed ID: 31626249)
1. Targeted covalent inhibition of O-GlcNAc transferase in cells.
Worth M; Hu CW; Li H; Fan D; Estevez A; Zhu D; Wang A; Jiang J
Chem Commun (Camb); 2019 Oct; 55(88):13291-13294. PubMed ID: 31626249
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.
Martin SES; Tan ZW; Itkonen HM; Duveau DY; Paulo JA; Janetzko J; Boutz PL; Törk L; Moss FA; Thomas CJ; Gygi SP; Lazarus MB; Walker S
J Am Chem Soc; 2018 Oct; 140(42):13542-13545. PubMed ID: 30285435
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
5. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA
Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374
[TBL] [Abstract][Full Text] [Related]
6. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Itkonen HM; Gorad SS; Duveau DY; Martin SE; Barkovskaya A; Bathen TF; Moestue SA; Mills IG
Oncotarget; 2016 Mar; 7(11):12464-76. PubMed ID: 26824323
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAc Transferase Regulates Angiogenesis in Idiopathic Pulmonary Arterial Hypertension.
Barnes JW; Tian L; Krick S; Helton ES; Denson RS; Comhair SAA; Dweik RA
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847126
[TBL] [Abstract][Full Text] [Related]
9. Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Rafie K; Gorelik A; Trapannone R; Borodkin VS; van Aalten DMF
Bioconjug Chem; 2018 Jun; 29(6):1834-1840. PubMed ID: 29723473
[TBL] [Abstract][Full Text] [Related]
10. Discovery of O-GlcNAc transferase inhibitors.
Gross BJ; Kraybill BC; Walker S
J Am Chem Soc; 2005 Oct; 127(42):14588-9. PubMed ID: 16231908
[TBL] [Abstract][Full Text] [Related]
11. An Economical High-Throughput "FP-Tag" Assay for Screening Glycosyltransferase Inhibitors*.
Yin X; Li J; Chen S; Wu Y; She Z; Liu L; Wang Y; Gao Z
Chembiochem; 2021 Apr; 22(8):1391-1395. PubMed ID: 33259119
[TBL] [Abstract][Full Text] [Related]
12. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.
Itkonen HM; Poulose N; Steele RE; Martin SES; Levine ZG; Duveau DY; Carelli R; Singh R; Urbanucci A; Loda M; Thomas CJ; Mills IG; Walker S
Mol Cancer Res; 2020 Oct; 18(10):1512-1521. PubMed ID: 32611550
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.
Angelova M; Ortiz-Meoz RF; Walker S; Knipe DM
J Virol; 2015 Aug; 89(16):8474-83. PubMed ID: 26041297
[TBL] [Abstract][Full Text] [Related]
15. Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.
Ryan P; Shi Y; von Itzstein M; Rudrawar S
Bioorg Chem; 2021 May; 110():104738. PubMed ID: 33667901
[TBL] [Abstract][Full Text] [Related]
16. A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase.
Jiang J; Lazarus MB; Pasquina L; Sliz P; Walker S
Nat Chem Biol; 2011 Nov; 8(1):72-7. PubMed ID: 22082911
[TBL] [Abstract][Full Text] [Related]
17. Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.
Borodkin VS; Schimpl M; Gundogdu M; Rafie K; Dorfmueller HC; Robinson DA; van Aalten DM
Biochem J; 2014 Feb; 457(3):497-502. PubMed ID: 24256146
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
[TBL] [Abstract][Full Text] [Related]
19. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
Qi J; Wang R; Zeng Y; Yu W; Gu Y
Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Cell-Permeable O-GlcNAc Transferase Inhibitors via Tethering in Situ Click Chemistry.
Wang Y; Zhu J; Zhang L
J Med Chem; 2017 Jan; 60(1):263-272. PubMed ID: 28032764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
